CRL Charles River Laboratories International, Inc.
Healthcare
Price
$278.98
Intrinsic value
$45.70
Buy price
$36.56
Discount
-510.4%
DCF walkthrough
Near-term growth (g1)0.33%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $737,646,000.00
- Total debt
- $3,034,319,104.00
- Cash & STI
- $192,024,992.00
- Shares out.
- 48,021,000
Overvalued [LOW CF reliability]
Intrinsic value$45.68
Buy price (with MOS)$36.55
Current price$278.98
Discount to intrinsic value-510.7%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 6.3%
- Current ROE
- -4.6%
- Minimum ROE
- -4.6%
Debt quality
MODERATE- Debt / Equity
- 0.96x
Moat proxy
WEAK_PROXYCash-flow reliability
LOW- Operating CF / Net income
- —
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(revenueCAGR,cfCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 59.9%
- Public economic interest
- 98.5%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.